Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42345 (
mTOR
)
26,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We previously proposed that high expression of
FAM129A
can be used as a thyroid carcinoma biomarker in preoperative diagnostic exams of thyroid nodules. Here, we identify that
FAM129A
expression is increased under nutrient and growth factor depletion in a normal thyroid cell line (PCCL3), overlapping with increased expression of autophagy-related protein and inhibition of AKT/
mTOR
/p70S6K. Supplementation of insulin, TSH and serum to the medium was able to reduce the expression of both
FAM129A
and autophagy-related protein and reestablish the AKT/
mTOR
/p70S6K axis. To determine the direct role of
FAM129A
on autophagy,
FAM129A
was transfected into PCCL3 cells. Its overexpression induced autophagic vesicles formation, evidenced by transmission electron microscopy. Co-expression of
FAM129A
and mCherry-EGFP-LC3B in PCCL3 showed an increased yellow puncta formation, suggesting that FAM129Ainduces autophagy. To further confirm its role on autophagy, we knockdown
FAM129A
in two thyroid carcinoma cell lines (TPC1 and FTC-236). Unexpectedly,
FAM129A
silencing increased autophagic flux, suggesting that
FAM129A
inhibits autophagy in these models. We next co-transfected PCCL3 cells with
FAM129A
and RET/PTC1 and tested autophagy in this context. Co-expression of
FAM129A
and RET/PTC1 oncogene in PCCL3 cells, inhibited RET/PTC1-induced autophagy. Together, our data suggest that, in normal cells
FAM129A
induces autophagy in order to maintain cell homeostasis and provide substrates under starvation conditions. Instead, in cancer cells, decreased autophagy may help the cells to overcome cell death.
FAM129A
regulates autophagy in a cell- and/or context-dependent manner. Our data reinforce the concept that autophagy can be used as a strategy for cancer treatment.
...
PMID:FAM129A regulates autophagy in thyroid carcinomas in an oncogene-dependent manner. 3040 8